Quest Diagnostics
DGX
#1100
Rank
โ‚น1.460 T
Marketcap
โ‚น13,087
Share price
-0.30%
Change (1 day)
17.66%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2023 (TTM): โ‚น557.67

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น585.08. In 2022 the company made an earnings per share (EPS) of โ‚น697.60 a decrease over its 2021 EPS that were of โ‚น1,374.

EPS history for Quest Diagnostics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น557.67-20.06%
2022โ‚น697.60-49.21%
2021โ‚น1,37449.72%
2020โ‚น917.4466.67%
2019โ‚น550.4618%
2018โ‚น466.51-4.26%
2017โ‚น487.2823.19%
2016โ‚น395.54-7.11%
2015โ‚น425.8328.46%
2014โ‚น331.49-31.61%
2013โ‚น484.6960.46%
2012โ‚น302.06-16.51%
2011โ‚น361.782.45%
2010โ‚น353.134.35%
2009โ‚น338.4130.77%
2008โ‚น258.7968.93%
2007โ‚น153.20-40.6%
2006โ‚น257.929.96%
2005โ‚น234.5510.39%
2004โ‚น212.4816.35%
2003โ‚น182.6226.73%
2002โ‚น144.1190.29%
2001โ‚น75.7353.51%
2000โ‚น49.33-22900%
1999-โ‚น0.22-101.11%
1998โ‚น19.47-216.88%
1997-โ‚น16.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น650.86 11.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น29.52-105.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น79.63-113.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น81.36-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น125.86-78.49%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands